TransMedics Group, Inc. TMDX Return on equity

Return on equity at other companies

CareDxCDNA

-2.4%-21.9pp

LivaNovaLIVN

-17.6%-19.5pp

SRT

Strata Critical MedicalSRTA

15.6%+10.0pp

Insight Molecular Diagnostics Inc.IMDX

-532.9%-717pp

ICU MedicalICUI

-0.4%-0.2pp

StereotaxisSTXS

-251.5%-29.9pp

FAQ

What is TransMedics Group, Inc.'s return on equity?

TransMedics Group, Inc. (TMDX) reported return on equity of 45.2% in Q1 2026.

How has TransMedics Group, Inc.'s return on equity changed year-over-year?

TransMedics Group, Inc.'s return on equity increased by 96.7% year-over-year, from 23% to 45.2%.

What is the long-term trend for TransMedics Group, Inc.'s return on equity?

Over 4 years (2020 to 2025), TransMedics Group, Inc.'s return on equity has grown at a 10.6% compound annual growth rate (CAGR), from -36.3% to 54.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.